A RG-II type polysaccharide purified from Aconitum coreanum alleviates lipopolysaccharide-induced inflammation by inhibiting the NF-κB signal pathway

PLoS One. 2014 Jun 13;9(6):e99697. doi: 10.1371/journal.pone.0099697. eCollection 2014.

Abstract

Korean mondshood root polysaccharides (KMPS) isolated from the root of Aconitum coreanum (Lévl.) Rapaics have shown anti-inflammatory activity, which is strongly influenced by their chemical structures and chain conformations. However, the mechanisms of the anti-inflammatory effect by these polysaccharides have yet to be elucidated. A RG-II polysaccharide (KMPS-2E, Mw 84.8 kDa) was isolated from KMPS and its chemical structure was characterized by FT-IR and NMR spectroscopy, gas chromatography-mass spectrometry and high-performance liquid chromatography. The backbone of KMPS-2E consisted of units of [→6) -β-D-Galp (1→3)-β-L-Rhap-(1→4)-β-D-GalpA-(1→3)-β-D-Galp-(1→] with the side chain →5)-β-D-Arap (1→3, 5)-β-D-Arap (1→ attached to the backbone through O-4 of (1→3,4)-L-Rhap. T-β-D-Galp is attached to the backbone through O-6 of (1→3,6)-β-D-Galp residues and T-β-D-Ara is connected to the end group of each chain. The anti-inflammatory effects of KMPS-2E and the underlying mechanisms using lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages and carrageenan-induced hind paw edema were investigated. KMPS-2E (50, 100 and 200 µg/mL) inhibits iNOS, TLR4, phospho-NF-κB-p65 expression, phosphor-IKK, phosphor-IκB-α expression as well as the degradation of IκB-α and the gene expression of inflammatory cytokines (TNF-α, IL-1β, iNOS and IL-6) mediated by the NF-κB signal pathways in macrophages. KMPS-2E also inhibited LPS-induced activation of NF-κB as assayed by electrophorectic mobility shift assay (EMSA) in a dose-dependent manner and it reduced NF-κB DNA binding affinity by 62.1% at 200 µg/mL. In rats, KMPS-2E (200 mg/kg) can significantly inhibit carrageenan-induced paw edema as ibuprofen (200 mg/kg) within 3 h after a single oral dose. The results indicate that KMPS-2E is a promising herb-derived drug against acute inflammation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aconitum / chemistry*
  • Animals
  • Blotting, Western
  • Cell Line
  • Electrophoretic Mobility Shift Assay
  • Inflammation / chemically induced*
  • Inflammation / drug therapy*
  • Lipopolysaccharides / pharmacology*
  • Magnetic Resonance Spectroscopy
  • Male
  • Mice
  • NF-kappa B / metabolism*
  • Plant Extracts / chemistry
  • Plant Extracts / therapeutic use*
  • Polysaccharides / chemistry
  • Polysaccharides / therapeutic use*
  • Rats
  • Rats, Wistar
  • Signal Transduction / drug effects

Substances

  • Lipopolysaccharides
  • NF-kappa B
  • Plant Extracts
  • Polysaccharides

Grants and funding

This study was supported by the Traditional Chinese Medicine Scientific Research Foundation of Shanghai Health Bureau (No. 2012J008A), the National Nature Science Foundation of China (No. 81373951), and the key New Drug Creation and Manufacturing Program in China (No. 2012ZX09301001-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.